Indoco Remedies Limited has informed the Exchange about re-appointment of Cost Auditor and Internal Auditor.
INDOCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indoco Remedies has informed the stock exchanges that its Board of Directors, at a meeting held on 31st March 2026, approved the re-appointment of M/s Joshi Apte and Associates as Cost Auditor and M/s Suresh Surana & Associates LLP as Internal Auditor for the financial year 2026-2027. Both firms are continuing in their existing roles, with no change in the audit structure. The Board meeting lasted just 16 minutes, indicating a short, procedural session. The disclosure is made under SEBI Listing Regulations to maintain compliance and transparency.
This is a routine compliance filing with no material impact on shareholders or the stock price. It simply confirms continuity of the company's existing audit firms for the upcoming financial year.